In 2017 we started our MedWatch Reporting Program. This ongoing program gives patients information to report their own benzodiazepine experiences to the FDA. So far it has been a success.
In September, 2020, the FDA finally took a look into this 60+ year prescribed patient pandemic, instituting a boxed warning about abuse, misuse and addiction, along with warnings about the prescribed issues of dependence and withdrawal.
An example of the old vs new FDA warning for diazepam (Valium):